Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Acuity, Inc. stock logo
AYI
Acuity
$298.43
-1.4%
$275.90
$216.81
$345.30
$9.28B1.62308,465 shs200,151 shs
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$103.16
-0.7%
$103.42
$71.88
$107.53
$153.66B0.686.70 million shs5.89 million shs
Colfax Co. stock logo
CFX
Colfax
$110.71
$35.66
$54.67
$6.30B2.121.39 million shs101,542 shs
Hovnanian Enterprises Inc stock logo
HOV
Hovnanian Enterprises
$119.73
-1.7%
$101.68
$81.15
$240.34
$721.86M2.1395,830 shs183,580 shs
Moderna, Inc. stock logo
MRNA
Moderna
$33.64
-1.9%
$27.21
$23.15
$129.39
$13.26B1.848.86 million shs6.92 million shs
Marathon Oil Co. stock logo
MRO
Marathon Oil
$28.55
$28.18
$25.54
$29.74
$15.97B2.165.90 million shsN/A
M&T Bank Corporation stock logo
MTB
M&T Bank
$201.67
-1.2%
$186.49
$150.75
$225.70
$32.75B0.631.19 million shs1.00 million shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Acuity, Inc. stock logo
AYI
Acuity
-1.42%-2.21%+8.87%+24.51%+24.89%
Boston Scientific Corporation stock logo
BSX
Boston Scientific
-0.61%-1.09%+3.80%+10.14%+33.78%
Colfax Co. stock logo
CFX
Colfax
0.00%0.00%0.00%0.00%0.00%
Hovnanian Enterprises Inc stock logo
HOV
Hovnanian Enterprises
-2.01%+5.65%+22.44%+33.71%-14.70%
Moderna, Inc. stock logo
MRNA
Moderna
-1.87%+10.40%+21.23%+28.40%-71.36%
Marathon Oil Co. stock logo
MRO
Marathon Oil
0.00%0.00%0.00%0.00%+1.35%
M&T Bank Corporation stock logo
MTB
M&T Bank
-1.09%-0.45%+9.28%+27.78%+32.35%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Acuity, Inc. stock logo
AYI
Acuity
4.7266 of 5 stars
2.35.01.71.84.12.52.5
Boston Scientific Corporation stock logo
BSX
Boston Scientific
4.6552 of 5 stars
3.63.00.04.23.22.51.3
Colfax Co. stock logo
CFX
Colfax
N/AN/AN/AN/AN/AN/AN/AN/A
Hovnanian Enterprises Inc stock logo
HOV
Hovnanian Enterprises
0.7799 of 5 stars
0.82.00.00.01.23.31.3
Moderna, Inc. stock logo
MRNA
Moderna
4.3068 of 5 stars
4.01.00.04.62.12.50.6
Marathon Oil Co. stock logo
MRO
Marathon Oil
0.591 of 5 stars
1.20.02.50.00.01.71.3
M&T Bank Corporation stock logo
MTB
M&T Bank
4.7618 of 5 stars
2.35.02.53.61.72.52.5
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Acuity, Inc. stock logo
AYI
Acuity
2.50
Moderate Buy$340.6014.13% Upside
Boston Scientific Corporation stock logo
BSX
Boston Scientific
3.13
Buy$116.0912.53% Upside
Colfax Co. stock logo
CFX
Colfax
0.00
N/AN/AN/A
Hovnanian Enterprises Inc stock logo
HOV
Hovnanian Enterprises
1.50
Reduce$120.000.22% Upside
Moderna, Inc. stock logo
MRNA
Moderna
2.04
Hold$46.6138.56% Upside
Marathon Oil Co. stock logo
MRO
Marathon Oil
2.40
Hold$30.506.83% Upside
M&T Bank Corporation stock logo
MTB
M&T Bank
2.57
Moderate Buy$211.484.86% Upside

Current Analyst Ratings Breakdown

Latest HOV, AYI, MTB, CFX, MRNA, MRO, and BSX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/2/2025
M&T Bank Corporation stock logo
MTB
M&T Bank
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$200.00 ➝ $212.00
6/27/2025
Acuity, Inc. stock logo
AYI
Acuity
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$335.00 ➝ $365.00
6/27/2025
Acuity, Inc. stock logo
AYI
Acuity
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$315.00 ➝ $335.00
6/27/2025
Acuity, Inc. stock logo
AYI
Acuity
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$285.00 ➝ $320.00
6/23/2025
M&T Bank Corporation stock logo
MTB
M&T Bank
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$195.00 ➝ $200.00
6/20/2025
M&T Bank Corporation stock logo
MTB
M&T Bank
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$206.00 ➝ $215.00
6/18/2025
Acuity, Inc. stock logo
AYI
Acuity
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetNeutral ➝ Neutral$295.00 ➝ $315.00
6/17/2025
Acuity, Inc. stock logo
AYI
Acuity
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$275.00 ➝ $285.00
6/16/2025
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
6/16/2025
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$118.00
6/11/2025
Hovnanian Enterprises Inc stock logo
HOV
Hovnanian Enterprises
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$120.00
(Data available from 7/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Acuity, Inc. stock logo
AYI
Acuity
$3.84B2.38$17.44 per share17.11$84.32 per share3.54
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$16.75B9.11$3.63 per share28.45$14.93 per share6.91
Colfax Co. stock logo
CFX
Colfax
$3.85B0.00N/A10.16$30.12 per share0.00
Hovnanian Enterprises Inc stock logo
HOV
Hovnanian Enterprises
$3.00B0.24$40.18 per share2.98$109.83 per share1.09
Moderna, Inc. stock logo
MRNA
Moderna
$3.24B4.02N/AN/A$28.33 per share1.19
Marathon Oil Co. stock logo
MRO
Marathon Oil
$6.70B2.38$6.49 per share4.40$20.44 per share1.40
M&T Bank Corporation stock logo
MTB
M&T Bank
$13.45B2.41$18.69 per share10.79$160.52 per share1.26
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Acuity, Inc. stock logo
AYI
Acuity
$422.60M$12.6923.5217.131.879.63%20.35%11.98%N/A
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$1.85B$1.3775.3031.942.7011.58%18.67%10.38%7/23/2025 (Estimated)
Colfax Co. stock logo
CFX
Colfax
$71.66M$0.4684.910.000.771.86%7.41%4.14%N/A
Hovnanian Enterprises Inc stock logo
HOV
Hovnanian Enterprises
$242.01M$28.554.19N/A7.03%33.18%8.41%8/20/2025 (Estimated)
Moderna, Inc. stock logo
MRNA
Moderna
-$3.56B-$8.73N/AN/AN/A-105.67%-28.69%-21.94%7/30/2025 (Estimated)
Marathon Oil Co. stock logo
MRO
Marathon Oil
$1.55B$2.3312.2512.92N/A19.73%12.80%7.35%N/A
M&T Bank Corporation stock logo
MTB
M&T Bank
$2.59B$14.9313.5110.801.4819.86%10.18%1.28%7/16/2025 (Estimated)

Latest HOV, AYI, MTB, CFX, MRNA, MRO, and BSX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2025Q2 2025
Moderna, Inc. stock logo
MRNA
Moderna
-$2.97N/AN/AN/A$116.26 millionN/A
7/23/2025Q2 2025
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$0.72N/AN/AN/A$4.89 billionN/A
7/16/2025Q2 2025
M&T Bank Corporation stock logo
MTB
M&T Bank
$4.02N/AN/AN/A$2.39 billionN/A
6/26/2025Q3 2025
Acuity, Inc. stock logo
AYI
Acuity
$4.44$5.12+$0.68$3.12$1.15 billion$1.18 billion
5/20/2025Q2 2025
Hovnanian Enterprises Inc stock logo
HOV
Hovnanian Enterprises
$2.45$2.43-$0.02$2.43$733.20 million$686.47 million
5/1/2025Q1 2025
Moderna, Inc. stock logo
MRNA
Moderna
-$2.92-$2.52+$0.40-$2.52$130.35 million$108.00 million
4/23/2025Q1 2025
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$0.67$0.75+$0.08$0.45$4.57 billion$4.66 billion
4/14/2025Q1 2025
M&T Bank Corporation stock logo
MTB
M&T Bank
$3.41$3.38-$0.03$3.32$2.35 billion$2.31 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Acuity, Inc. stock logo
AYI
Acuity
$0.680.23%N/A5.36%3 Years
Boston Scientific Corporation stock logo
BSX
Boston Scientific
N/AN/AN/AN/AN/A
Colfax Co. stock logo
CFX
Colfax
N/AN/AN/AN/AN/A
Hovnanian Enterprises Inc stock logo
HOV
Hovnanian Enterprises
N/AN/AN/AN/AN/A
Moderna, Inc. stock logo
MRNA
Moderna
N/AN/AN/AN/AN/A
Marathon Oil Co. stock logo
MRO
Marathon Oil
$0.441.54%N/A18.88%2 Years
M&T Bank Corporation stock logo
MTB
M&T Bank
$5.402.68%N/A36.17%N/A

Latest HOV, AYI, MTB, CFX, MRNA, MRO, and BSX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/26/2025
Acuity, Inc. stock logo
AYI
Acuity
quarterly$0.170.2%7/18/20257/18/20258/1/2025
5/20/2025
M&T Bank Corporation stock logo
MTB
M&T Bank
quarterly$1.352.91%6/2/20256/2/20256/30/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Acuity, Inc. stock logo
AYI
Acuity
0.39
1.99
1.38
Boston Scientific Corporation stock logo
BSX
Boston Scientific
0.47
1.45
0.88
Colfax Co. stock logo
CFX
Colfax
0.45
2.25
1.49
Hovnanian Enterprises Inc stock logo
HOV
Hovnanian Enterprises
0.11
1.58
0.28
Moderna, Inc. stock logo
MRNA
Moderna
N/A
4.22
4.14
Marathon Oil Co. stock logo
MRO
Marathon Oil
0.40
0.69
0.61
M&T Bank Corporation stock logo
MTB
M&T Bank
0.39
0.97
0.97

Institutional Ownership

CompanyInstitutional Ownership
Acuity, Inc. stock logo
AYI
Acuity
98.21%
Boston Scientific Corporation stock logo
BSX
Boston Scientific
89.07%
Colfax Co. stock logo
CFX
Colfax
91.99%
Hovnanian Enterprises Inc stock logo
HOV
Hovnanian Enterprises
65.40%
Moderna, Inc. stock logo
MRNA
Moderna
75.33%
Marathon Oil Co. stock logo
MRO
Marathon Oil
77.24%
M&T Bank Corporation stock logo
MTB
M&T Bank
84.68%

Insider Ownership

CompanyInsider Ownership
Acuity, Inc. stock logo
AYI
Acuity
2.80%
Boston Scientific Corporation stock logo
BSX
Boston Scientific
0.50%
Colfax Co. stock logo
CFX
Colfax
8.20%
Hovnanian Enterprises Inc stock logo
HOV
Hovnanian Enterprises
19.77%
Moderna, Inc. stock logo
MRNA
Moderna
11.00%
Marathon Oil Co. stock logo
MRO
Marathon Oil
0.35%
M&T Bank Corporation stock logo
MTB
M&T Bank
0.53%
CompanyEmployeesShares OutstandingFree FloatOptionable
Acuity, Inc. stock logo
AYI
Acuity
13,20030.65 million29.79 millionOptionable
Boston Scientific Corporation stock logo
BSX
Boston Scientific
53,0001.48 billion1.47 billionOptionable
Colfax Co. stock logo
CFX
Colfax
16,200161.33 million148.10 millionOptionable
Hovnanian Enterprises Inc stock logo
HOV
Hovnanian Enterprises
1,8785.92 million4.75 millionNot Optionable
Moderna, Inc. stock logo
MRNA
Moderna
5,800386.74 million344.20 millionOptionable
Marathon Oil Co. stock logo
MRO
Marathon Oil
1,681559.41 million557.45 millionOptionable
M&T Bank Corporation stock logo
MTB
M&T Bank
22,354160.52 million159.67 millionOptionable

Recent News About These Companies

J.P. Morgan Keeps Their Hold Rating on M&T Bank (MTB)
MTB approves 10% stock dividend at 26th AGM
M&T Bank (NYSE:MTB) Price Target Raised to $212.00

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Acuity stock logo

Acuity NYSE:AYI

$298.43 -4.26 (-1.41%)
Closing price 07/11/2025 03:58 PM Eastern
Extended Trading
$298.73 +0.29 (+0.10%)
As of 07/11/2025 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Acuity Brands, Inc. provides lighting, lighting controls, building management system, location-aware applications in the United States and internationally. The company operates in two segments, Acuity Brands Lighting and Lighting Controls (ABL); and the Intelligent Spaces Group (ISG). The ABL segment provides commercial, architectural, and specialty lighting solutions, as well as lighting controls and components for various indoor and outdoor applications under the A-Light, Aculux, American Electric Lighting, Cyclone, Dark to Light, eldoLED, Eureka, Gotham, Healthcare Lighting, Holophane, Hydrel, Indy, IOTA, Juno, Lithonia Lighting, Luminaire LED, Luminis, Mark Architectural Lighting, nLight, OPTOTRONIC, Peerless, RELOCWiring Solutions, and Sensor Switch. This segment serves electrical distributors, retail home improvement centers, electric utilities, national accounts, original equipment manufacturers, digital retailers, lighting showrooms, and energy service companies. The ISG segment offers building management solutions, such as products for controlling heating, ventilation, air conditioning, lighting, shades, refrigeration, and building access that deliver end-to-end optimization of those building systems; and building management software that enhances building system management and automates labor intensive tasks. This segment serves system integrators, as well as retail stores, airports, and enterprise campuses. The company offers its products and solutions under the Atrius, Distech Controls, and KE2 Therm Solutions brands. Acuity Brands, Inc. was incorporated in 2001 and is headquartered in Atlanta, Georgia.

Boston Scientific stock logo

Boston Scientific NYSE:BSX

$103.16 -0.70 (-0.67%)
Closing price 07/11/2025 03:59 PM Eastern
Extended Trading
$103.02 -0.13 (-0.13%)
As of 07/11/2025 07:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Colfax stock logo

Colfax NYSE:CFX

Colfax Corp. operates as a diversified technology company. The firm provides orthopedic care and fabrication technology products and services to customers. It operates through the following segments: Medical Technology and Fabrication Technology. The Medical Technology segment develops, manufactures and distributes medical devices used for rehabilitation, pain management and physical therapy. The Fabrication Technology develops, manufactures and supplies consumable products and equipment. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Wilmington, DE.

Hovnanian Enterprises stock logo

Hovnanian Enterprises NYSE:HOV

$119.73 -2.11 (-1.73%)
Closing price 07/11/2025 03:58 PM Eastern
Extended Trading
$119.44 -0.30 (-0.25%)
As of 07/11/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Hovnanian Enterprises, Inc., through its subsidiaries, designs, constructs, markets, and sells residential homes in the United States. It offers single-family detached homes, attached townhomes and condominiums, urban infill, and active lifestyle homes with amenities, such as clubhouses, swimming pools, tennis courts, tot lots, and open areas. The company markets and builds homes for first-time buyers, first-time and second-time move-up buyers, luxury buyers, active lifestyle buyers, and empty nesters. It also provides mortgage loans, title insurance, and homeowner's insurance services. The company was founded in 1959 and is headquartered in Matawan, New Jersey.

Moderna stock logo

Moderna NASDAQ:MRNA

$33.64 -0.64 (-1.87%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$33.57 -0.07 (-0.21%)
As of 07/11/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Marathon Oil stock logo

Marathon Oil NYSE:MRO

Marathon Oil Corporation, an independent exploration and production company, engages in exploration, production, and marketing of crude oil and condensate, natural gas liquids, and natural gas in the United States and internationally. The company also produces and markets products manufactured from natural gas, such as liquefied natural gas and methanol. In addition, it owns and operates Sugarloaf gathering system, a natural gas pipeline. The company was formerly known as USX Corporation and changed its name to Marathon Oil Corporation in December 2001. Marathon Oil Corporation was founded in 1887 and is headquartered in Houston, Texas.

M&T Bank stock logo

M&T Bank NYSE:MTB

$201.67 -2.38 (-1.17%)
Closing price 07/11/2025 03:59 PM Eastern
Extended Trading
$204.50 +2.83 (+1.40%)
As of 07/11/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

M&T Bank Corp. operates as a bank holding company, which engages in the provision of retail and commercial banking, trust, wealth management, and investment services. It operates through the following segments: Commercial Bank, Retail Bank, Institutional Services and Wealth Management, and All Other. The Commercial Bank segment offers a wide range of credit products and banking services to middle-market and large commercial customers, mainly within the markets served by the company. The Retail Bank segment refers to the services to consumers and small businesses through the company’s branch network and several other delivery channels such as telephone banking, internet banking, and ATMs. The Institutional Services and Wealth Management segment relates to helping high net worth individuals, institutions, and families grow, preserve, and transfer wealth. The All Other segment reflects other activities of the company that are not directly attributable to the reported segments. The company was founded on August 30, 1856 and is headquartered in Buffalo, NY.